FARMAC
ActiveFARMAC has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.16M and a net result of €306k. Equity is growing by ~17% per year across the filed fiscal years. Its solvency ranks better than 43% of 7760 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
64
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability75▼-4
Solvency63=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €130k at 30 days acceptable
Liquidity ample (current ratio 1.53 against 1.54 in 2024; short-term debt: 45.7% and cash: 2.3% of total assets), but 61.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 43
Relative position
BE, all sectors
reference
Sector 43
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
38.1%
Return on assets
5.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
29 d early
2024
38 d early
2023
37 d early
2022
12 d early
2021
24 d early
2020
25 d early
2019
35 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€2.16M▲ 6.2%
2024 · €2.03M
2018: €462k
2019: €574k
2020: €982k
2021: €1.44M
2022: €1.64M
2023: €1.79M
2024: €2.03M
2018 → 2025
Total assets
€5.67M▲ 7.1%
2024 · €5.30M
2018: €2.70M
2019: €3.07M
2020: €2.65M
2021: €3.15M
2022: €4.06M
2023: €4.85M
2024: €5.30M
2018 → 2025
Net result
€306k▼ 27.4%
2024 · €422k
2018: €411k
2019: €362k
2020: €588k
2021: €781k
2022: €377k
2023: €335k
2024: €422k
2018 → 2025
Working capital
€1.37M▲ 5.9%
2024 · €1.29M
2018: €91k
2019: €218k
2020: €584k
2021: €812k
2022: €847k
2023: €954k
2024: €1.29M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.44M-€1.64M▲ 13.7%€1.79M▲ 9.4%€2.03M▲ 13.5%€2.16M▲ 6.2%
Operating result€1.04M-€535k▼ 48.4%€536k▲ 0.2%€701k▲ 30.7%€534k▼ 23.9%
Net result€781k-€377k▼ 51.7%€335k▼ 11.3%€422k▲ 26.0%€306k▼ 27.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 24% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.67M
Fixed assets
€1.71M▲ 7.6%
Current assets
€3.96M▲ 6.9%
Equity and liabilities €5.67M
Equity
€2.16M▲ 6.2%
Debt
€3.51M▲ 7.6%
The debt ratio rises from 61.6% to 61.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€1.08M▼
2024 · €1.18M
Cash flow
€847k▼
2024 · €899k
Solvency
38.1%▼
2024 · 38.4%
Current ratio
1.53▼
2024 · 1.54
Quick ratio
0.75▼
2024 · 0.92
Debt / equity
1.62▲
2024 · 1.60
ROE
14.2%▼
2024 · 20.7%
ROA
5.4%▼
2024 · 8.0%
Interest coverage
10.47▲
2024 · 10.09
Debt
€3.51M▲
2024 · €3.26M
Debt ≤ 1 year
€2.59M▲
2024 · €2.42M
Debt > 1 year
€916k▲
2024 · €845k
Income taxes
€125k▼
2024 · €163k
Staff costs
€3.24M▲
2024 · €2.74M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€5.30M€5.67M▲
Fixed assets21/28€1.59M€1.71M▲
Intangible fixed assets21€2k€2k▼
Tangible fixed assets22/27€1.58M€1.70M▲
Plant, machinery and equipment23€518k€394k▼
Furniture and vehicles24€573k€472k▼
Leasing and similar rights25€388k€745k▲
Other tangible fixed assets26€102k€90k▼
Financial fixed assets28€2k€4k▲
Current assets29/58€3.71M€3.96M▲
Stocks and contracts in progress3€1.48M€2.02M▲
Contracts in progress37€1.48M€2.02M▲
Amounts receivable within one year40/41€1.40M€1.71M▲
Trade receivables40€1.15M€1.40M▲
Other amounts receivable41€246k€308k▲
Cash at bank and in hand54/58€752k€128k▼
Deferred charges and accrued income490/1€78k€107k▲
Equity and liabilities
Total equity and liabilities10/49€5.30M€5.67M▲
Equity10/15€2.03M€2.16M▲
Contributions10/11€19k€19k=
Reserves13€353k€353k=
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Tax-exempt reserves132€351k€56k▼
Distributable reserves133€2k€297k▲
Profit (loss) carried forward14€1.66M€1.79M▲
Amounts payable17/49€3.26M€3.51M▲
Amounts payable after more than one year17€845k€916k▲
Financial debts170/4€845k€916k▲
Amounts payable within one year42/48€2.42M€2.59M▲
Current portion of amounts payable after more than one year42€648k€548k▼
Financial debts43€701k€701k=
Credit institutions430/8€701k€701k=
Trade debts44€556k€773k▲
Suppliers440/4€556k€773k▲
Taxes, remuneration and social security45€307k€388k▲
Taxes450/3€13k€6k▼
Remuneration and social security454/9€294k€381k▲
Other amounts payable47/48€204k€185k▼
Income statement
Code20242025
Non-recurring operating income76A€0€1k▲
Remuneration, social security and pensions62€2.74M€3.24M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€478k€541k▲
Other operating charges640/8€43k€43k▲
Non-recurring operating charges66A€0€6k▲
Gross operating margin9900€3.96M€4.37M▲
Operating profit (loss)9901€701k€534k▼
Financial income75/76B€480€179▼
Recurring financial income75€480€179▼
Financial charges65/66B€117k€103k▼
Recurring financial charges65€117k€103k▼
Profit (loss) for the period before taxes9903€585k€432k▼
Income taxes67/77€163k€125k▼
Profit (loss) for the period9904€422k€306k▼
Transfer from tax-exempt reserves789-€295k
Profit (loss) for the period to be appropriated9905€422k€601k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.84M€2.26M▲
Profit (loss) brought forward from the previous period14P€1.42M€1.66M▲
Transfer to equity691/2-€295k
To other reserves6921-€295k
Profit to be distributed694/7€180k€180k=
Return on contributions (dividend)694€180k€180k=
Social balance
Average headcount (FTE)908747.349.0▲
The notes to these accounts (26 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Weakest financial yearnet €306k ▼27.4%
Net result drops to €306k, the lowest in the series.
23-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €2MEq €2.03M ▲13.5%
7 profitable years in a row build equity to €2.03M.
24-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
19-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €781k ▲32.7%
Operating result €1.04M, net result €781k, both a record.
31-12
Financial
Equity above €1MEq €1.44M ▲46.8%
4 profitable years in a row build equity to €1.44M.
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
26-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Equity above €500kEq €574k ▲24.3%
2 profitable years in a row build equity to €574k.
09-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
27-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
07-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Peer · 1 establishment unit since 2000
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Nijverheidsstraat 63990 PeerGround area
6,852 m²
Building footprint
1,812 m²
Volume, LiDAR
11,784 m³
Parcel 72030A0588/00M000, Flanders · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
FARMAC BVBA
since 20002.115.867.829
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72030A0588/00M000 | Flanders | 6,852 m² | 1 · 1,812 m² | 8.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 9 entries · 72,247 EUR awarded · 71,831 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 21,579 EUR | 21,203 EUR |
| 2024 | 2 | 14,302 EUR | 14,364 EUR |
| 2023 | 3 | 20,595 EUR | 20,950 EUR |
| 2022 | 2 | 15,771 EUR | 15,314 EUR |
Schemes
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Subsidies ecologisch en veilig transport (stopgezet)
Recognitions · licences · registrations
Recognised contractor
7 categoriesFARMAC BV26474
Similar companies · same sector, comparable size
DYMOTEC
BE 0460.004.088
Olen · Eq €2.16M
CK TECHNOLOGY
BE 0458.532.658
Visé · Eq €2.17M
ECO HEATING
BE 0893.919.633
Melle · Eq €2.15M
ALFA SUN
BE 0810.424.805
Sint-Agatha-Berchem · Eq €2.15M
GIJSELS
BE 0467.085.088
Ranst · Eq €2.18M
Of 22,826 companies in sector 43211 we hold annual accounts for 10,327. 2,722 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-07-2000
Fiscal year end31-12
Activities, NACEBEL
43211General electrical installation work
45310
42211Civil engineering
42220Construction of utility projects for electricity and telecommunications
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.